Robot or laparoscope? trial pits two surgical approaches for obesity Head-to-Head
NCT ID NCT06629662
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This trial compares robotic and laparoscopic sleeve gastrectomy in people with obesity to see which approach is faster and safer. Participants are randomly assigned to one of the two surgical methods. The study measures operative time, bleeding, and complications like leaks or conversions to open surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sleeve gastrectomy (laparoscopic or robotic)
- What this could lead to
- If robotic surgery proves faster or safer, it could become the preferred approach for weight-loss surgery.
- What could go wrong
- This is a small, early-stage comparison. Robotic surgery may take longer and cost more without clear benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Naples Federico II
Naples, Italy, 80131, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test